Published on Monday May 06, 2013
Starts registration of beta and gamma interferons
Smooth Drug Development started registration of beta and gamma interferons. Smooth Drug Development will provide the following services to the client, who is a leading biotechnology company in Russia:
- Drug dossier preparation
- Pre-clinical studies
- Essential documents preparation
- Clinical trials conduct
- Final report
Biosimilars are generic biopharmaceutical products. Today's biosimilar market is developing and it has great opportunities for future growth.
Biosimilar trials – a research conducted to prove that the analogue drug has similar safety and therapeutic profile as the original.